Trial
NCT02327182
Safety Study of MT-4666 in Subjects With Alzheimer's Disease
Phase IIITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Tanabe Pharma Corporation
Collaborators
—
Condition
Alzheimer's Disease
Intervention
MT-4666
Why stopped
This study was terminated due to the benefit-risk balance of MT-4666.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-11-13